Sandoz International

Activities: Pharmaceutical

Trending Articles

  1. Sartorius Stedim Biotech supports bioprocess development with new Innovation Centre The Massachusetts, US-based Centre for Bioprocess Innovation is a collaborative space designed to develop and optimise biomanufacturing processes
  2. IMed Consultancy helps Toby Orthopaedics navigate UK regulations Regulatory consultancy ensures compliance and confidence for Miami-based company
  3. Aurobindo Pharma signs $25m respiratory drug development and commercialisation deal with global pharma company The companies will co-develop and commercialise respiratory therapeutics, diversifying Aurobindo's current portfolio
  4. IMed supports K2 medical systems in their EU MDR transition Consultancy firm helps K2 navigate the complex regulatory process to achieve Article 97 compliance
  5. Steritas and argenx join forces to advance steroid-sparing therapeutic development With the help of Steritas' STOX Suite, argenx aims to develop antibody-based therapeutics for immune diseases, potentially allowing patients to move away from chronic steroid...

Upcoming event

CPhI Middle East

10–12 December 2024 | Conference | Riyadh, Saudi Arabia See all

Related Content

Sustainability

Sandoz and Teva achieve independent certification for steps to minimise antimicrobial resistance risk

Certification demonstrates their commitment to protecting people and the planet
Manufacturing

Sandoz opens new packaging centre in Stryków, Poland

The generics division of Novartis has invested €42m in the project
Pharmaceutical

Nick Haggar of Sandoz to become new EGA President

Takes up the role on 8 October
Media

Asia and Latin America will drive biosimilars growth in next decade, says Visiongain

Established players will focus on monoclonal antibodies and licensing deals
Ingredients

Sandoz begins clinical trial of biosimilar rituximab

Aims to demonstrate the bioequivalence of the monoclonal antibody
Regulatory

FDA approves first generic version of Lovenox

Sanofi-aventis has reservations about Sandoz drug for treating DVT
Finance

Sandoz to acquire Oriel Therapeutics

Deal will give Sandoz rights to portfolio of respiratory products targeting asthma and COPD
Subscribe now